Skip to main content

Table 1 Details on current anti-malarial agents

From: Exploring anti-malarial potential of FDA approved drugs: an in silico approach

Drug name

Drug class

Anti-malarial activity

Side effects

Quinine

Cinchona alkaloids

Accumulates in food vacuoles and forms toxic haem complexes

Side effects include hearing impairment, rashes, vertigo, vomiting and in some cases neurotoxicity

Quinidine

Mefloquine

Quinolines and derivatives

Nausea, dizziness, diarrhoea, bradycardia and neurotoxicity

Chloroquine

May cause psoriasis

Amodiaquine

Vomiting, dizziness and in some cases hepatic disorders

Primaquine

 

Believed to block oxidative metabolism in the parasite

Anorexia, vomiting, cramps and anaemia

Halofantrine

Phenanthrenes and derivatives

Causes parasite membrane damage by forming cytotoxic complexes

Nausea, diarrhoea, itching and high cardiotoxicity

Sulfadoxine

Benzene and substituted derivatives

Inhibit synthesis of folates

Skin reactions (rare)

Sulfamethoxypyridazine

Proguanil

Very few: hair loss and mouth ulcers

Pyrimethamine

Diazines

Occasional rashes

Tetracycline

Tetracyclines

Inhibits translation

–

Doxycycline

Depression of bone growth and gastrointestinal disturbances

Clindamycin

Carboxylic acids and derivatives

Inhibits protein synthesis

Nausea, vomiting and cramps

Azithromycin

Macrolides and analogues

May cause angioedema and jaundice

Artemisinin

Lipids and lipid-like molecules

Believed to affect mitochondrial electron transport chain [46] or disrupt cellular redox cycling or inhibition of haem metabolism [47]

Nausea, anorexia, dizziness and neurotoxicity

Atovaquone

Naphthalenes

Affects mitochondrial electron transport chain

May cause rashes, diarrhoea and headache

  1. DrugBank (v.4.3) [26]. The drugs highlighted in italics denote anti-bacterials repurposed for use against malaria